Identification of pathological RA endotypes using blood-based biomarkers reflecting tissue metabolism. A retrospective and explorative analysis of two phase III RA studies

por Blair, J. P. M., Bager, C., Platt, A., Karsdal, M., Bay-Jensen, A. -C.
Publicado 2019

Identification of heterogenous treatment response trajectories to anti-IL6 receptor treatment in rheumatoid arthritis

por Blair, J. P. M., Bay-Jensen, A.-C., Tang, M. H., Frederiksen, P., Bager, C., Karsdal, M., Brunak, S.
Publicado 2020

Cathepsin-S degraded decorin are elevated in fibrotic lung disorders – development and biological validation of a new serum biomarker

por Kehlet, S.N., Bager, C.L., Willumsen, N., Dasgupta, B., Brodmerkel, C., Curran, M., Brix, S., Leeming, D.J., Karsdal, M. A.
Publicado 2017

A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis

por Leeming, D.J., Willumsen, N., Sand, J.M.B., Holm Nielsen, S., Dasgupta, B., Brodmerkel, C., Curran, M., Bager, C.L., Karsdal, MA.
Publicado 2018